Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Al-Aqar Healthcare REITXKLS:5116 -0.85%70 5-Year Yield-on-Cost % is 6.71 as of Jul. 22, 2026, which is 6% above its 10-year median of 6.31. GuruFocus rates XKLS:5116 with a GF Score™ of 70/100 and a GF Value™ of RM1.32 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 868 REITs companies, Al-Aqar Healthcare REIT ranks worse than 54.95% on this metric.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Al-Aqar Healthcare REIT 5-Year Yield-on-Cost % Related Terms
XKLS:5116 vs WELL, VTR, DOC: 5-Year Yield-on-Cost % Comparison
For the REIT - Healthcare Facilities subindustry, Al-Aqar Healthcare REIT's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Al-Aqar Healthcare REIT 5-Year Yield-on-Cost % vs REITs Industry
For the REITs industry and Real Estate sector, Al-Aqar Healthcare REIT's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Al-Aqar Healthcare REIT's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Al-Aqar Healthcare REIT (XKLS:5116) has a 5-Year Yield-on-Cost % of 6.71 as of Jul. 22, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Al-Aqar Healthcare REIT and its competitors. This is near median its historical median of 6.31. Over the past decade, Al-Aqar Healthcare REIT's 5-Year Yield-on-Cost % has ranged from 2.24 to 9.27. According to the industry distribution chart, Al-Aqar Healthcare REIT ranks #477 out of 868 companies in the REITs industry, placing it in the top 55%.
Is Al-Aqar Healthcare REIT's 5-Year Yield-on-Cost % too high?
Al-Aqar Healthcare REIT's current 5-Year Yield-on-Cost % of 6.71 is near median its 10-year median of 6.31. Over the past 10 years, this metric has ranged from a low of 2.24 to a high of 9.27. The REITs industry median 5-Year Yield-on-Cost % is 7.30. Al-Aqar Healthcare REIT's value of 6.71 is 8% below this industry median. Based on the distribution chart, Al-Aqar Healthcare REIT ranks #477 out of 868 companies in the REITs industry, which is below the industry midpoint. Overall, Al-Aqar Healthcare REIT has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Al-Aqar Healthcare REIT's 5-Year Yield-on-Cost % compare to WELL and VTR?
According to the REITs industry distribution chart, Al-Aqar Healthcare REIT ranks #477 out of 868 companies for 5-Year Yield-on-Cost %. This places Al-Aqar Healthcare REIT in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 7.30. Al-Aqar Healthcare REIT's value of 6.71 is 8% below this benchmark. Historically, Al-Aqar Healthcare REIT's own 5-Year Yield-on-Cost % has ranged from 2.24 to 9.27 over the past decade. While the company's 10-year median is 6.31 vs. the industry median of 7.30, Al-Aqar Healthcare REIT has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a REITs company?
The median 5-Year Yield-on-Cost % among REITs companies is 7.30, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Al-Aqar Healthcare REIT's current 5-Year Yield-on-Cost % of 6.71 is 8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Al-Aqar Healthcare REIT and its competitors. For the REITs industry, the median 5-Year Yield-on-Cost % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Al-Aqar Healthcare REIT's current 5-Year Yield-on-Cost % is 6.71, which is near median its own 10-year median of 6.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Al-Aqar Healthcare REIT stock overvalued right now?
Based on GuruFocus' analysis, Al-Aqar Healthcare REIT (XKLS:5116) is currently considered Modestly Undervalued. The stock's GF Value™ is RM1.32, compared to a current price of RM1.16 — trading 12.1% below its estimated fair value. The current 5-Year Yield-on-Cost % is 6.71, which is near median its 10-year median of 6.31 and 8% below the REITs industry median of 7.30. Al-Aqar Healthcare REIT's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Al-Aqar Healthcare REIT (XKLS:5116), the current 5-Year Yield-on-Cost % is 6.71 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Al-Aqar Healthcare REIT (XKLS:5116) Overvalued in 2026?
Based on GuruFocus' analysis, Al-Aqar Healthcare REIT stock appears to be undervalued.
The current stock price of RM1.16 is trading 12.1% below its estimated GF Value™ of RM1.32.
GuruFocus considers Al-Aqar Healthcare REIT to be Modestly Undervalued.
Key valuation signals for XKLS:5116:
5-Year Yield-on-Cost %: 6.71 (near median its 10-year median of 6.31)
GF Value™: RM1.32 vs. price of RM1.16 (12.1% below fair value)
Industry Position: 8% below the REITs median (#477 of 868)
No single metric tells the full story. See the XKLS:5116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Al-Aqar Healthcare REIT is engaged in investing in Syariah-compliant properties with the primary objective of providing unitholders with distribution and potential for the sustainable long-term growth of such distribution and capital appreciation. The company operates in Malaysia and Australia. The Malaysian geographic segment generates the maximum revenue for the company.
70GF Score
Get the complete analysis for XKLS:5116
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5116 has been successfully added to your 
